Latest Presentations

Enabling Tools that Allow Medicinal Chemist to Explore the hit to Lead Process in Parallel

Dr. Steve Jordan, Director of Chemistry R&D; for Biotage Discovery Chemistry Group, speaking at MedChem Europe 2006.

Date Posted: Wednesday, August 09, 2006

Print Email to a friend

To purchase a DVD containing all of the presentations featured at MedChem Europe 2006 please go to the Select Biosciences website.

Click here to launch presentation

About the Speaker

Steve Jordan is the Director of Chemistry R&D; for Biotage Discovery Chemistry Group. He joined Biotage with the acquisition of Argonaut in June 2005 where he was responsible for providing direction and vision in the development of new tools for chemists engaged in parallel medicinal chemistry.

Prior to that he was the Director of Analytical Sciences at Millennium Pharmaceuticals in the UK and was responsible for a number of groups engaged in analytical and physicochemical science. He was also responsible for compound management.

While at Roche Discovery Welwyn from 1974-1998, Steve gained a broad scientific knowledge of the drug discovery process and most notably was responsible for a number of projects including separation sciences, high-throughput chemistry, purification and analysis.

Related Products

Biotage and Chemspeed Introduce Microwave Synthesis Workstation
Microwave synthesis workstation ‘SWAVE’ offers ability to fully automate the synthesis process.

Related news from our archive

Biotage and Shanghai Chempartner Sign Multi-Instrument Deal
Shanghai Chempartner has invested in Biotage SP automated flash instruments and Initiator microwave synthesizers with delivery scheduled over the next 12 months.

Biotage AB and McMaster University Sign Agreement to Develop new Chemistry Platform
Biotage will provide funding and instruments to the University to develop molecular imaging agents for PET and SPECT and radiotherapy agents for treatment applications.

Biotage Makes a Change in Top Management after Business Area President Resigns
David Patteson, President of the business area Discovery Chemistry will leave the company on 1 April 2006.